Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Sarah Brend

Physician Assistant, Medical Dakota Dunes, SD Physician Assistant

NPI 1780988600 CMS profile 10764881

455 N Sioux Point Rd, Dakota Dunes, SD 57049

Open in the dashboard

General payments

$2,916

171 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Sarah Brend of Dakota Dunes, SD is reported in the CMS Open Payments database as having received $2,916 across 171 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 81st percentile of Physician Assistant, Medical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $652 40
2024 General $577 30
2023 General $665 45
2022 General $670 45
2021 General $353 11

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Sarah Brend
  • Physician Assistant, Medical median
  • Middle half of Physician Assistant, Medical
  • National median

In program year 2025, general payments to Sarah Brend were reported at $652. Among 16,675 Physician Assistant, Medical profiles paid that year, the median was $214 and the middle half received between $62 and $755.

Show as a table
Year Sarah Brend Physician Assistant, Medical median Middle half National median
2019 $0 $61 $19–$193 $163
2020 $0 $20 $14–$64 $114
2021 $353 $156 $41–$563 $132
2022 $670 $185 $55–$649 $149
2023 $665 $199 $58–$717 $160
2024 $577 $206 $62–$740 $164
2025 $652 $214 $62–$755 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Sumitomo Pharma America, Inc. $429 40 payments
  2. Astellas Pharma US Inc $255 10 payments
  3. Urogen Pharma, Inc. $210 5 payments
  4. AbbVie, Inc. $167 9 payments
  5. Myovant Sciences Inc. $152 17 payments
  6. Pfizer Inc. $150 8 payments
  7. Novartis Pharmaceuticals Corporation $130 5 payments
  8. Janssen Biotech, Inc. $117 7 payments
  9. Tolmar, Inc. $110 6 payments
  10. Medtronic, Inc. $106 3 payments
  11. Other $1,092 61 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $2,851 170 payments
  2. Education $65 1 payment
Products named General payments · program years 2021–2025
  1. ORGOVYX Hormone Therapy $410 41 payments
  2. XTANDI $274 13 payments
  3. JELMYTO $157 3 payments
  4. ORGOVYX Oncology $150 8 payments
  5. PLUVICTO $130 5 payments
  6. ORGOVYX Prostate Cancer $123 14 payments
  7. ERLEADA $117 7 payments
  8. INTERSTIM $106 3 payments
  9. BOTOX $101 5 payments
  10. Nubeqa $99 5 payments
  11. Other $1,794 100 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 23 drugs

Part D claims

1,610

Median for Physician Assistant: 241

Drug cost

$84,291

Median for Physician Assistant: $4,110

Branded share of claims

20.9%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Myrbetriq Mirabegron Brand 129 $50,816
Tamsulosin Hcl Generic 477 $8,331
Trospium Chloride Generic 114 $4,278
Potassium Citrate Er Potassium Citrate Brand 43 $4,200
Finasteride Generic 358 $4,015
Solifenacin Succinate Generic 14 $1,879
Methenamine Hippurate Generic 35 $1,870
Oxybutynin Chloride Er Oxybutynin Chloride Brand 42 $1,265
Nitrofurantoin Nitrofurantoin Macrocrystal Brand 45 $1,261
Testosterone Cypionate Generic 23 $1,133

The 10 drugs with the highest cost, of 23 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 55 billing codes

Paid by Medicare

$84,735

Of which drugs: $30,128

Medicare patients

458

Average age 75

Services billed

6,242

121 women, 337 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 70%
Arthritis 42%
Cancer 35%
Diabetes 29%
Chronic kidney disease 27%
Ischemic heart disease 21%
Atrial fibrillation 19%
Depression 15%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Leuprolide acetate (for depot suspension), 7.5 mg J9217 Office 16 87 $12,123

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 13 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
ORGOVYX
  • Sumitomo Pharma America, Inc. $115
  • PFIZER INC. $28
$143 — —
BOTOX
  • AbbVie, Inc. $69
$69 — —
PLUVICTO
  • Novartis Pharmaceuticals Corporation $61
$61 — —
PROVENGE
  • Dendreon Pharmaceuticals LLC $34
$34 — —
XTANDI
  • PFIZER INC. $28
$28 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 13 in the dashboard with a free account

Records

171 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant, Medical in South Dakota

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record